Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program
AC Gunes, N Ozgul, M Turkyılmaz, F Kara… - Cancer …, 2023 - Wiley Online Library
Objective To evaluate colposcopy performance following the human papillomavirus (HPV)
DNA screening program in Turkey. Methods Women aged 30–65 years are screened for …
DNA screening program in Turkey. Methods Women aged 30–65 years are screened for …
Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program.
AC Gunes, N Ozgul, M Turkyılmaz, F Kara… - Cancer …, 2023 - search.ebscohost.com
Objective: To evaluate colposcopy performance following the human papillomavirus (HPV)
DNA screening program in Turkey. Methods: Women aged 30–65 years are screened for …
DNA screening program in Turkey. Methods: Women aged 30–65 years are screened for …
Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program
AC Gunes, N Ozgul, M Turkyılmaz, F Kara… - Cancer …, 2023 - search.proquest.com
Methods Women aged 30–65 years are screened for cervical cancer every 5 years, with
individuals positive for HPV 16 and/or 18 or other high-risk HPV types with abnormal …
individuals positive for HPV 16 and/or 18 or other high-risk HPV types with abnormal …
Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program.
AC Gunes, N Ozgul, M Turkyılmaz, F Kara, F Unlu… - Cancer …, 2023 - europepmc.org
Methods Women aged 30-65 years are screened for cervical cancer every 5 years, with
individuals positive for HPV 16 and/or 18 or other high-risk HPV types with abnormal …
individuals positive for HPV 16 and/or 18 or other high-risk HPV types with abnormal …
[HTML][HTML] Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program
AC Gunes, N Ozgul, M Turkyılmaz, F Kara, F Unlu… - Cancer …, 2023 - ncbi.nlm.nih.gov
Methods Women aged 30–65 years are screened for cervical cancer every 5 years, with
individuals positive for HPV 16 and/or 18 or other high‐risk HPV types with abnormal …
individuals positive for HPV 16 and/or 18 or other high‐risk HPV types with abnormal …
Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program
A Gunes, N ÖZGÜL, M Turkyılmaz, F Kara… - Cancer …, 2023 - avesis.hacettepe.edu.tr
Objective: To evaluate colposcopy performance following the human papillomavirus (HPV)
DNA screening program in Turkey. Methods: Women aged 30–65 years are screened for …
DNA screening program in Turkey. Methods: Women aged 30–65 years are screened for …
Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program
AC Gunes, N Ozgul, M Turkyılmaz, F Kara… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate colposcopy performance following the human papillomavirus (HPV)
DNA screening program in Turkey. Methods Women aged 30-65 years are screened for …
DNA screening program in Turkey. Methods Women aged 30-65 years are screened for …
Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program.
AC Gunes, N Ozgul, M Turkyılmaz, F Kara, F Unlu… - Cancer …, 2023 - europepmc.org
Methods Women aged 30-65 years are screened for cervical cancer every 5 years, with
individuals positive for HPV 16 and/or 18 or other high-risk HPV types with abnormal …
individuals positive for HPV 16 and/or 18 or other high-risk HPV types with abnormal …